Discovery of Common Minor Histocompatibility Antigens Based on Patient Outcomes and Genomic Data
Author Information
Author(s): Armistead Paul M., Liang Shoudan, Li Hua, Lu Sijie, Van Bergen Cornelis A. M., Alatrash Gheath, St. John Lisa, Hunsucker Sally A., Sarantopoulos Stefanie, Falkenburg J. H. Frederik, Molldrem Jeffrey J.
Primary Institution: M.D. Anderson Cancer Center
Hypothesis
Common, immunodominant minor histocompatibility antigens (mHAs) can mediate clinically significant graft versus leukemia (GvL) and/or graft versus host disease (GvHD), and can be identified through genomic data correlated with clinical outcomes.
Conclusion
The study successfully identified a common mHA, T4A, which is associated with improved overall and disease-free survival in myeloid leukemia patients undergoing stem cell transplantation.
Supporting Evidence
- T4A mHA mismatches occurred at the maximum theoretical frequency for any given SCT.
- T4A-specific CD8+ T lymphocytes were detected in 3 of 4 evaluable post-transplant patients predicted to have a T4A mismatch.
- The study combined clinical outcomes data with genomics and bioinformatics methods to predict and confirm a mHA.
Takeaway
Researchers found a new target that helps the immune system fight leukemia after a stem cell transplant, which could lead to better treatments.
Methodology
The study genotyped 57 myeloid leukemia patients and their donors at 13,917 cSNPs and correlated genetic disparities with clinical outcomes.
Potential Biases
Potential biases may arise from the limited cohort size and the specific patient selection criteria.
Limitations
The small sample size limits the ability to draw definitive conclusions about the impact of T4A on survival and relapse outcomes.
Participant Demographics
{"median_age":48,"gender_distribution":{"male":37,"female":20},"disease_types":{"AML":29,"CML":17,"MDS":11}}
Statistical Information
P-Value
0.019
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website